Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Long-Term Debt (Tables)

Long-Term Debt (Tables)

9 Months Ended

Sep. 30, 2019

Schedule of Maturities of Long-term Debt

The following table presents scheduled principal payments of the Company’s long-term debt and final payment fee as of September 30, 2019:



Period	Amount
Remainder of 2019	$	583
2020	2,333
2021	440
Total principal payments	3,356
Less accreted portion of final payment fee, net of issuance cost and success fee discounts	51
Long-term debt, net	$	3,305

Current portion	$	2,333
Long-term portion	972
Long-term debt, net	$	3,305

Schedule of Debt

The following table sets forth interest expense information related to the long-term debt, including interest expense associated with the final payment and initial success fee, for the periods presented:



	Three Months Ended				Nine Months Ended
	September 30, 2019		September 30, 2018		September 30, 2019		September 30, 2018
Contractual interest expense	$	63	$	106	$	228	$	343
Amortization of debt issuance costs	4		7		16		25
Accretion of final payment	11		19		40		64
Amortization of initial success fee	5		9		19		30
	$	83	$	141	$	303	$	462